<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00128453</url>
  </required_header>
  <id_info>
    <org_study_id>DCASL30501-1</org_study_id>
    <secondary_id>EUDRACT number 2005-001570-28</secondary_id>
    <nct_id>NCT00128453</nct_id>
  </id_info>
  <brief_title>Study of Colchicine to Treat Acute Pericarditis and Prevent Recurrences</brief_title>
  <official_title>Treatment and Prevention of Pericarditis With Colchicine. A Multicenter Double Blind Randomized Trial. The ICAP Trial: Investigation on Colchicine for Acute Pericarditis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Azienda Sanitaria Locale 3, Torino</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Azienda Sanitaria Locale 3, Torino</source>
  <brief_summary>
    <textblock>
      The purpose of the study is to determine whether colchicine is safe and effective in the
      treatment of acute pericarditis and the prevention of subsequent recurrences.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Colchicine is safe and effective in the management of recurrent pericarditis after failure of
      conventional treatment. Preliminary data have shown that it may be effective also in
      treatment of the index attack of pericarditis and the prevention of further recurrences.

      Comparisons: The study will compare the safety and efficacy of colchicine in the treatment of
      acute pericarditis and the primary prevention of recurrences. Colchicine will be used in
      addition to conventional treatment.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>August 2005</start_date>
  <completion_date type="Actual">June 2012</completion_date>
  <primary_completion_date type="Actual">June 2012</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Recurrence rate at 18 months</measure>
    <time_frame>18 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Symptom persistence at 72 hours, remission rate at 1 week</measure>
    <time_frame>1 week</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of recurrences</measure>
    <time_frame>18 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to first recurrence</measure>
    <time_frame>18 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Disease-related re-hospitalization, cardiac tamponade, constrictive pericarditis within the duration of the study</measure>
    <time_frame>18 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">240</enrollment>
  <condition>Pericarditis</condition>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Conventional therapy plus placebo</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Colchicine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Conventional therapy plus colchicine</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Colchicine (for 3 months)</intervention_name>
    <description>Colchicine 0.5mg BID (patients&gt;70Kg) or 0.5mg once daily</description>
    <arm_group_label>Colchicine</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>placebo</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with acute pericarditis (index attack)

          -  Ageâ‰¥ 18 years

          -  Informed consent

        Exclusion Criteria:

          -  Suspected neoplastic, tuberculous, or purulent etiology

          -  Known severe liver disease and/or elevated transaminases &gt;1.5 times the upper limit of
             normality

          -  Serum creatinine &gt;2.5 mg/dl

          -  Serum creatine kinase (CK) over the upper limit of normality or known myopathy

          -  Known gastrointestinal or blood disease

          -  Pregnant or lactating women or women not protected by a contraception method

          -  Known hypersensibility to colchicine

          -  Treatment with colchicine at enrolment
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Rita TRINCHERO, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Cardiology Department. Maria Vittoria Hospital, ASL 3 Torino. Italy.</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Massimo IMAZIO, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Cardiology Department. Maria Vittoria Hospital, ASL 3 Torino. Italy.</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Massimo IMAZIO, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Cardiology Department. Maria Vittoria Hospital, ASL 3 Torino. Italy.</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Cardiology Department. Maria Vittoria Hospital, ASL 3 Torino</name>
      <address>
        <city>Torino.</city>
        <state>Torino</state>
        <zip>10141</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Internal Medicine Division</name>
      <address>
        <city>Bergamo</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cardiology Department-Ospedale Regionale</name>
      <address>
        <city>Bolzano</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ospedale di Rivoli</name>
      <address>
        <city>Rivoli</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <reference>
    <citation>Imazio M, Cecchi E, Ierna S, Trinchero R; ICAP Investigators. Investigation on Colchicine for Acute Pericarditis: a multicenter randomized placebo-controlled trial evaluating the clinical benefits of colchicine as adjunct to conventional therapy in the treatment and prevention of pericarditis; study design amd rationale. J Cardiovasc Med (Hagerstown). 2007 Aug;8(8):613-7.</citation>
    <PMID>17667033</PMID>
  </reference>
  <verification_date>June 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 8, 2005</study_first_submitted>
  <study_first_submitted_qc>August 8, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 10, 2005</study_first_posted>
  <last_update_submitted>June 6, 2012</last_update_submitted>
  <last_update_submitted_qc>June 6, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 7, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Pericarditis</keyword>
  <keyword>Recurrence</keyword>
  <keyword>Therapeutics</keyword>
  <keyword>Prevention</keyword>
  <keyword>Colchicine</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pericarditis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Colchicine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

